Axsome Therapeutics, Inc. (AXSM) vs Bruker Corporation (BRKR)
A side-by-side comparison of Axsome Therapeutics, Inc. and Bruker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXSM
Axsome Therapeutics, Inc.
$174.60HealthcareDelayed quote: Oct 6, 2026, 9:35 AM EDT
BRKR
Bruker Corporation
$65.69HealthcareDelayed quote: Oct 6, 2026, 9:35 AM EDT
Total return — AXSM vs BRKR
growth of $100 · dividends reinvested · last 10yAXSM +2067.4% (+36.0%/yr)BRKR +196.6% (+11.5%/yr)AXSM compounded faster over this window
Log scale — wide-divergence pair
AXSM BRKR
AXSM vs BRKR: by the numbers
- •BRKR is the larger company ($10.00B vs $8.98B market cap).
- •Both run net losses; BRKR's is the smaller (-2.03% vs -24.68% net margin).
- •BRKR pays a dividend (0.23% yield), while AXSM has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | AXSM | BRKR |
|---|---|---|
| Forward P/E | N/A | 30.96 |
| P/S ratio | 11.57 | 2.86 |
| P/B ratio | 107.86 | 4.17 |
| EV / EBITDA | N/A | 32.89 |
| FCF yield | N/A | 0.94% |
Profitability
| Metric | AXSM | BRKR |
|---|---|---|
| Gross margin | 93.24% | 46.69% |
| Operating margin | -24.28% | 3.61% |
| Net margin | -24.68% | -2.03% |
| ROE | -230.05% | -2.97% |
| ROIC | -50.82% | 2.56% |
Dividends
| Metric | AXSM | BRKR |
|---|---|---|
| Dividend yield | N/A | 0.23% |
Growth (annualized)
| Metric | AXSM | BRKR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.10% |
| FCF CAGR (5Y) | N/A | -21.33% |
| Total return CAGR (5Y) | 41.40% | -3.42% |
Frequently asked
- Does AXSM or BRKR pay a bigger dividend?
- BRKR pays a dividend (0.23% yield), while AXSM has no payments in the available dividend history.
- How have AXSM and BRKR total returns compared?
- Over the past 10 years, AXSM delivered 35.76% and BRKR delivered 11.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bruker dividend yieldAxsome Therapeutics ROEBruker ROEAxsome Therapeutics operating marginBruker operating marginAxsome Therapeutics revenue growthBruker revenue growthAxsome Therapeutics free cash flowBruker free cash flow
Axsome Therapeutics & Bruker appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.